Alignment Healthcare president sells 30,000 shares
Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock at a weighted-average price of $19.5475 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock at a weighted-average price of $19.5475 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on May 22, 2025. After this sale, she directly holds 947,313 shares, indicating a large remaining ownership position.
Insider Trade Summary 10b5-1
Net Seller: 30,000 shares
Net Sell
1 txn
Insider
Maroney Dawn Christine
Role
President
Sold
30,000 shs ($586K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,000 | $19.5475 | $586K |
Holdings After Transaction:
Common Stock — 947,313 shares (Direct)
Footnotes (2)
- F1. Date of Rule 10b5-1 plan adoption: 05/22/2025
- F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.19 to $19.80. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Key Figures
Shares sold: 30,000 shares
Weighted-average sale price: $19.5475 per share
Post-transaction holdings: 947,313 shares
+2 more
5 metrics
Shares sold
30,000 shares
Open-market sale of common stock on June 15, 2026
Weighted-average sale price
$19.5475 per share
Average price for 30,000 shares sold
Post-transaction holdings
947,313 shares
Directly held by Dawn Christine Maroney after sale
Price range of trades
$19.19–$19.80 per share
Range of individual sale prices within the transaction
Rule 10b5-1 plan adoption date
May 22, 2025
Date the trading plan governing this sale was adopted
Key Terms
Rule 10b5-1 plan, weighted-average price, open-market sale, Form 4
4 terms
Rule 10b5-1 plan regulatory
"Date of Rule 10b5-1 plan adoption: 05/22/2025"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Alignment Healthcare (ALHC) report for Dawn Christine Maroney?
Alignment Healthcare reported that president Dawn Christine Maroney sold 30,000 shares of common stock in an open-market transaction. The shares were sold at a weighted-average price of $19.5475 per share, as part of a previously adopted Rule 10b5-1 trading plan.
Was the Alignment Healthcare (ALHC) insider sale under a Rule 10b5-1 plan?
Yes. The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted on May 22, 2025. Such pre-arranged plans allow insiders to systematically sell shares according to preset instructions, helping separate trading decisions from day-to-day company news.
What does the weighted-average price mean in the Alignment Healthcare (ALHC) Form 4?
The weighted-average price of $19.5475 reflects multiple trades executed between $19.19 and $19.80 per share. The insider undertook to provide full details of the number of shares sold at each price within that range to the company, any security holder, or the SEC staff upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
